Diva Laboratories, Ltd.(TW:4153)
NT$31.30+0.35 (+3.47%)
TW:4153
Diva Laboratories, Ltd. financials statements
NT$31.30
At close:+0.35 (+3.47%)
Diva Laboratories, Ltd. (4153) Ratios
Diva Laboratories, Ltd. Ratios
TW:4153's free cash flow for Q2 2026 was NT$72.72M. For the 2026 fiscal year, TW:4153's free cash flow was decreased by NT$-58.00K and operating cash flow was NT$72.78M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.35 | 4.18 | 4.70 | 4.16 | 4.55 |
| Quick Ratio | 2.58 | 3.56 | 3.74 | 2.80 | 2.72 |
| Cash Ratio | 1.53 | 2.39 | 2.64 | 1.48 | 1.56 |
| Solvency Ratio | 0.31 | 0.42 | 0.39 | 0.25 | 0.18 |
| Operating Cash Flow Ratio | 0.06 | 0.50 | 1.24 | 0.31 | -0.06 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 3.81 | -0.91 |
| Net Current Asset Value | NT$ 759.85M | NT$ 781.11M | NT$ 745.47M | NT$ 740.77M | NT$ 679.30M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.32 | 1.24 | 1.20 | 1.23 | 1.20 |
| Debt Service Coverage Ratio | 392.53 | 511.26 | 264.63 | 5.89 | 2.84 |
| Interest Coverage Ratio | 426.06 | 542.28 | 280.10 | 607.87 | 224.47 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.05 | 0.09 | 0.13 | 0.01 | 0.01 |
| Net Debt to EBITDA | -4.37 | -4.60 | -5.23 | -2.62 | -7.07 |
| Profitability Margins | |||||
| Gross Profit Margin | 30.46% | 30.17% | 28.06% | 28.04% | 25.50% |
| EBIT Margin | 11.77% | 13.47% | 10.31% | 7.15% | 4.01% |
| EBITDA Margin | 12.94% | 14.74% | 11.32% | 13.94% | 5.94% |
| Operating Profit Margin | 11.77% | 12.89% | 10.31% | 12.87% | 3.47% |
| Pretax Profit Margin | 12.52% | 13.45% | 9.82% | 7.13% | 4.00% |
| Net Profit Margin | 10.42% | 10.86% | 8.24% | 5.23% | 3.07% |
| Continuous Operations Profit Margin | 10.42% | 10.86% | 8.24% | 5.34% | 2.76% |
| Net Income Per EBT | 83.26% | 80.78% | 83.88% | 73.42% | 76.77% |
| EBT Per EBIT | 106.35% | 104.30% | 95.24% | 55.36% | 115.30% |
| Return on Assets (ROA) | 6.69% | 7.17% | 5.92% | 3.97% | 1.85% |
| Return on Equity (ROE) | 8.80% | 8.87% | 7.13% | 4.89% | 2.22% |
| Return on Capital Employed (ROCE) | 9.93% | 10.50% | 8.86% | 12.01% | 2.50% |
| Return on Invested Capital (ROIC) | 8.24% | 8.46% | 7.41% | 8.65% | 1.89% |
| Return on Tangible Assets | 6.69% | 7.18% | 5.92% | 3.97% | 1.86% |
| Earnings Yield | 4.41% | 4.17% | 3.40% | 2.09% | 1.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.83 | 3.03 | 4.40 | 3.15 | 3.50 |
| Payables Turnover | 7.80 | 8.52 | 10.53 | 8.02 | 5.11 |
| Inventory Turnover | 2.42 | 3.98 | 3.28 | 2.14 | 1.51 |
| Fixed Asset Turnover | 4.00 | 3.87 | 3.84 | 4.21 | 3.13 |
| Asset Turnover | 0.64 | 0.66 | 0.72 | 0.76 | 0.60 |
| Working Capital Turnover Ratio | 1.12 | 1.12 | 1.20 | 1.33 | 1.05 |
| Cash Conversion Cycle | 233.12 | 169.51 | 159.65 | 241.03 | 275.27 |
| Days of Sales Outstanding | 129.00 | 120.57 | 82.95 | 115.91 | 104.38 |
| Days of Inventory Outstanding | 150.93 | 91.79 | 111.36 | 170.62 | 242.34 |
| Days of Payables Outstanding | 46.80 | 42.85 | 34.66 | 45.50 | 71.45 |
| Operating Cycle | 279.93 | 212.36 | 194.31 | 286.53 | 346.72 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.35 | 2.10 | 4.29 | 1.25 | -0.19 |
| Free Cash Flow Per Share | 0.34 | 2.06 | 4.17 | 1.05 | -0.41 |
| Dividend Paid and CapEx Coverage Ratio | 0.18 | 1.63 | 3.82 | 2.21 | -0.41 |
| Capital Expenditure Coverage Ratio | 20.77 | 57.78 | 33.78 | 6.41 | -0.89 |
| Operating Cash Flow Coverage Ratio | 7.16 | 24.77 | 33.70 | 258.61 | -27.71 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.14 | 0.28 | 0.08 | -0.02 |
| Free Cash Flow Yield | 0.96% | 5.39% | 11.32% | 2.60% | -1.54% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 22.66 | 23.91 | 29.44 | 47.71 | 72.43 |
| Price-to-Sales (P/S) Ratio | 2.36 | 2.60 | 2.42 | 2.51 | 2.21 |
| Price-to-Book (P/B) Ratio | 1.99 | 2.13 | 2.10 | 2.34 | 1.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 103.79 | 18.54 | 8.83 | 38.51 | -64.86 |
| Price-to-Operating Cash Flow Ratio | 98.79 | 18.22 | 8.57 | 32.51 | -138.04 |
| Price-to-Earnings Growth (PEG) Ratio | -6.04 | 0.85 | 0.63 | 0.37 | 1.71 |
| Enterprise Value Multiple | 13.88 | 13.06 | 16.18 | 15.37 | 30.11 |
| Enterprise Value | 1.56B | 1.66B | 1.64B | 2.03B | 1.27B |
| EV to EBITDA | 13.88 | 13.06 | 16.18 | 15.37 | 30.11 |
| EV to Sales | 1.80 | 1.92 | 1.83 | 2.14 | 1.79 |
| EV to Free Cash Flow | 78.95 | 13.72 | 6.67 | 32.91 | -52.53 |
| EV to Operating Cash Flow | 75.15 | 13.48 | 6.48 | 27.78 | -111.80 |
| Tangible Book Value Per Share | 17.49 | 17.96 | 17.52 | 17.30 | 16.65 |
| Shareholders’ Equity Per Share | 17.51 | 17.99 | 17.54 | 17.32 | 16.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.19 | 0.16 | 0.27 | 0.23 |
| Revenue Per Share | 14.78 | 14.70 | 15.18 | 16.18 | 12.14 |
| Net Income Per Share | 1.54 | 1.60 | 1.25 | 0.85 | 0.37 |
| Tax Burden | 0.83 | 0.81 | 0.84 | 0.73 | 0.77 |
| Interest Burden | 1.06 | 1.00 | 0.95 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.08 | 0.08 | 0.08 | 0.09 | 0.10 |
| SG&A to Revenue | 0.09 | 0.10 | 0.10 | 0.10 | 0.12 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.19 | 1.06 | 3.44 | 1.08 | -0.40 |
Currency in TWD
